Market closedNon-fractional

Harvard Bioscience/HBIO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Harvard Bioscience

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Ticker

HBIO

Sector

Healthcare

Trading on

NASDAQ

Industry

Life Sciences Tools and Services

Headquarters

Holliston, United States

Employees

404

HBIO Metrics

BasicAdvanced
$118M
Market cap
-
P/E ratio
-$0.20
EPS
1.46
Beta
-
Dividend rate
$118M
1.46
1.875
0.762
46.344
51.75
-0.46%
-0.69%
-12.20%
1.089
1.73
-46.51
10.752
-6.76%
306.99%
0.46%
26.21%

What the Analysts think about HBIO

Analyst Ratings

Majority rating from 3 analysts.
Buy

HBIO Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-18.77% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$25M
-12.81%
Net income
-$4.6M
155.56%
Profit margin
-18.77%
193.28%

HBIO Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 14.28%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.04
$0.01
$0.04
$0.02
-
Expected
$0.06
$0.04
$0.05
$0.02
$0.05
Surprise
-36.84%
-75.00%
-20.00%
-14.28%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Harvard Bioscience stock?

Harvard Bioscience (HBIO) has a market cap of $118M as of July 06, 2024.

What is the P/E ratio for Harvard Bioscience stock?

The price to earnings (P/E) ratio for Harvard Bioscience (HBIO) stock is 0 as of July 06, 2024.

Does Harvard Bioscience stock pay dividends?

No, Harvard Bioscience (HBIO) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Harvard Bioscience dividend payment date?

Harvard Bioscience (HBIO) stock does not pay dividends to its shareholders.

What is the beta indicator for Harvard Bioscience?

Harvard Bioscience (HBIO) has a beta rating of 1.46. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Harvard Bioscience stock

Buy or sell Harvard Bioscience stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing